Thank you.
Dr. Nuyt, you talked about the delays in getting approval for pediatric medications that aren't approved here but are already approved by the FDA, and I think you said EMA is the comparable organization in Europe. You also talked about accessing pediatric formulas.
In COVID we saw jurisdictions around the world all independently having to decide on approving different vaccines and different treatments for COVID, which would seem to me to be a rather inefficient process. I don't know about you, but working as a doctor, one of the wonderful things I've found about medicine is that it's universal. People all around the world suffer from basically the same problems. When you open someone up, they're exactly the same.
Now I'm going to ask you a bit of a political question.
Given the delays in getting approval, and delays in smaller countries like Canada, which fall behind bigger countries.... The FDA, for instance, has more people and probably more ability to rapidly assess which drugs should be approved. Does it make sense that every country has its own regulatory process? Do you think we ought to be considering more of a global approach in terms of an international regulatory system to test and approve new vaccines and drugs so that when we have something like COVID again or when there are new outbreaks of antimicrobial resistance, we're better able to respond rapidly to these problems globally?